Qin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qin Wang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Hao Zhang
Department of Clinical Laboratory the Second Affiliated Hospital of Anhui Medical University Hefei China
9 shared publications- Qiang Zhou
Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui Medical University, Hefei, China
8 shared publications Futing Liu
Department of Clinical Laboratory the Second Affiliated Hospital of Anhui Medical University Hefei China
6 shared publicationsQian Liu
Department of Clinical Laboratory the Second Affiliated Hospital of Anhui Medical University Hefei China
6 shared publicationsWanlu Duan
Department of Clinical Laboratory the Second Affiliated Hospital of Anhui Medical University Hefei China
6 shared publicationsJianfei Li
Department of Clinical Laboratory, The Second Affiliated Hospital of Anhui Medical University , Hefei , 230601 , China
5 shared publications
Latest Publications
- Open Access
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1738116
Association between peripheral IFN-γ+ cytotoxic lymphocytes and response to PD-1/PD-L1-based therapy in hepatocellular carcinoma
Background: Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint therapy (ICT), either alone or in combination with tyrosine kinase inhibitors (TKIs) or bevacizumab, benefits a subset of patients with hepatocellular carcinoma (HCC), and reliable predictive biomarkers remain limited. Methods: Between August 2024 and July 2025, 55 HCC patients treated with PD-1-based therapies were included. Objective response rate (ORR) was assessed according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST). Peripheral cytotoxic lymphocyte subsets and effector functions were profiled by multiparameter flow cytometry. Results: We observed that the ICT plus TKI group exhibited a higher ORR than ICT monotherapy (54.5% vs. 29.4%; n = 22 vs. n = 17), whereas the ORR in the ICT plus bevacizumab group was comparable to ICT monotherapy (37.5% vs. 29.4%; n = 16 vs. n = 17). Compared with ICT monotherapy, patients receiving ICT plus TKI therapy had higher peripheral CD8 ⁺ cytotoxic T lymphocyte (CTL) proportions and elevated percentages of IFN-γ + CTLs, natural killer (NK) cells, and natural killer T (NKT) cells (all P < 0.05). Across all treatment regimens, IFN-γ + cytotoxic lymphocytes frequencies were associated with treatment response and showed good discrimination, whereas circulating serum IFN-γ levels were not informative. Conclusion: These findings support peripheral IFN-γ + cytotoxic lymphocytes as a candidate noninvasive biomarker for stratifying HCC patients receiving PD-1/PD-L1-based therapy.
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1738116
Open AccessAssociation between peripheral IFN-γ+ cytotoxic lymphocytes and response to PD-1/PD-L1-based therapy in hepatocellular carcinoma
Background: Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1)-based immune checkpoint therapy (ICT), either alone or in combination with tyrosine kinase inhibitors (TKIs) or bevacizumab, benefits a subset of patients with hepatocellular carcinoma (HCC), and reliable predictive biomarkers remain limited. Methods: Between August 2024 and July 2025, 55 HCC patients treated with PD-1-based therapies were included. Objective response rate (ORR) was assessed according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST). Peripheral cytotoxic lymphocyte subsets and effector functions were profiled by multiparameter flow cytometry. Results: We observed that the ICT plus TKI group exhibited a higher ORR than ICT monotherapy (54.5% vs. 29.4%; n = 22 vs. n = 17), whereas the ORR in the ICT plus bevacizumab group was comparable to ICT monotherapy (37.5% vs. 29.4%; n = 16 vs. n = 17). Compared with ICT monotherapy, patients receiving ICT plus TKI therapy had higher peripheral CD8 ⁺ cytotoxic T lymphocyte (CTL) proportions and elevated percentages of IFN-γ + CTLs, natural killer (NK) cells, and natural killer T (NKT) cells (all P < 0.05). Across all treatment regimens, IFN-γ + cytotoxic lymphocytes frequencies were associated with treatment response and showed good discrimination, whereas circulating serum IFN-γ levels were not informative. Conclusion: These findings support peripheral IFN-γ + cytotoxic lymphocytes as a candidate noninvasive biomarker for stratifying HCC patients receiving PD-1/PD-L1-based therapy.
- Open Access
- 12 January 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (1) , e70118
Intrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection
Backgrounds and Aims: CD8+T cells are crucially associated with the fight against hepatitis B virus (HBV) infection. CD161 has been shown to express remarkably on HCV‐specific CD8+T cells. However, the accurate function of CD161+CD8+T cells in HBV immunity or pathogenesis remains undetermined.Methods: Blood samples were collected from 25 chronic hepatitis B (CHB) patients. Peripheral blood levels of CD161+CD8+T cells and their correlation with serum ALT levels were analyzed in CHB patients. To analyze the in vivo CD161+CD8+T cell's number, function, and intrahepatic recruitment characteristics, HBV replication mouse models were established. The expression of CD161 on HBV‐specific CD8+T cells was also detected by analyzing CD161+CD8+T cell functions during infection.Results: Patients with CHB infection had a markedly lower peripheral blood frequency of CD161+CD8+T cells than did healthy controls and negatively correlated with serum ALT level. Furthermore, compared to the control mice, the frequency of CD161+CD8+T cells was significantly decreased in the blood of acute and chronic HBV‐replicating mice. Moreover, CHB‐replicating mice had significantly increased hepatic levels of CD161+CD8+T cells, which was not observed in the acute group of mice. Additionally, the CD161+CD8+T cells were categorized into CD161hi and CD161intCD8+T cells and it was revealed that in the liver of CHB‐replicating mice the primary recruited cells were CD161hiCD8+T. Intrahepatic CD161hiCD8+T cells demonstrated increased CXCR6 expression, enhanced production of cytokine IL‐17 and TNF‐ɑ, and reduced IFN‐γ secretion. Accordingly, the CXCL16 mRNA expression in the liver tissue of CHB‐replication mice was markedly higher than in acute HBV‐replicating and control mice. The study also revealed that HBV‐specific CD8+T cells were mainly CD161‐CD8+T cells.Conclusion: During HBV infection, the intrahepatic recruitment of CD161+CD8+T cells was mainly CD161hiCD8+T cell subpopulation, which has a weak antiviral response, but increased pro‐inflammatory effect, suggesting that CD161 may serve as a potential marker of liver‐damaging T cells.
- 12 January 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (1) , e70118
Open AccessIntrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection
Backgrounds and Aims: CD8+T cells are crucially associated with the fight against hepatitis B virus (HBV) infection. CD161 has been shown to express remarkably on HCV‐specific CD8+T cells. However, the accurate function of CD161+CD8+T cells in HBV immunity or pathogenesis remains undetermined.Methods: Blood samples were collected from 25 chronic hepatitis B (CHB) patients. Peripheral blood levels of CD161+CD8+T cells and their correlation with serum ALT levels were analyzed in CHB patients. To analyze the in vivo CD161+CD8+T cell's number, function, and intrahepatic recruitment characteristics, HBV replication mouse models were established. The expression of CD161 on HBV‐specific CD8+T cells was also detected by analyzing CD161+CD8+T cell functions during infection.Results: Patients with CHB infection had a markedly lower peripheral blood frequency of CD161+CD8+T cells than did healthy controls and negatively correlated with serum ALT level. Furthermore, compared to the control mice, the frequency of CD161+CD8+T cells was significantly decreased in the blood of acute and chronic HBV‐replicating mice. Moreover, CHB‐replicating mice had significantly increased hepatic levels of CD161+CD8+T cells, which was not observed in the acute group of mice. Additionally, the CD161+CD8+T cells were categorized into CD161hi and CD161intCD8+T cells and it was revealed that in the liver of CHB‐replicating mice the primary recruited cells were CD161hiCD8+T. Intrahepatic CD161hiCD8+T cells demonstrated increased CXCR6 expression, enhanced production of cytokine IL‐17 and TNF‐ɑ, and reduced IFN‐γ secretion. Accordingly, the CXCL16 mRNA expression in the liver tissue of CHB‐replication mice was markedly higher than in acute HBV‐replicating and control mice. The study also revealed that HBV‐specific CD8+T cells were mainly CD161‐CD8+T cells.Conclusion: During HBV infection, the intrahepatic recruitment of CD161+CD8+T cells was mainly CD161hiCD8+T cell subpopulation, which has a weak antiviral response, but increased pro‐inflammatory effect, suggesting that CD161 may serve as a potential marker of liver‐damaging T cells.
- Open Access
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 20 (1) , 20220951
Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
A growing body of evidence has shown that hepatitis B surface antigen (HBsAg) mutations can influence the occurrence of occult hepatitis B infection (OBI), particularly amino acid substitutions in small hepatitis B surface proteins (SHBs). The mechanistic basis for these results, however, remains unclear. This study was designed to explore the potential impact and mechanisms of OBI-related SHBs mutations on serum HBsAg. Huh7 and HepG2 cells were transfected with plasmids encoding wild-type (WT) or OBI-related SHB mutation-containing sequences, after which a chemiluminescence approach was used to detect HBsAg levels in cell culture supernatants. Western blotting was further used to assess HBsAg and endoplasmic reticulum stress (ERS)-related protein levels in lysates prepared from these cells, while the localization of HBsAg within cells was assessed via immunofluorescent staining. Cells transfected with OBI-related SHB mutation-encoding plasmids exhibited lower supernatant HBsAg levels than cells transfected with WT plasmids. Intracellular and extracellular HBsAg levels in these mutant plasmid-transfected cells were lower relative to those for WT plasmid-transfected cells, and HBsAg accumulation within the ER was detected via immunofluorescent staining in cells transfected with OBI-related SHB mutation-encoding plasmids, ERS-related protein content was also significantly increased in mutant plasmid-transfected cells as compared to those in the WT group. These results suggest that proteins harboring OBI-related mutations may tend to accumulate in the ER, thereby triggering an ERS response and impairing the transcription and translation of HBsAg via the activation of the unfolded protein response and ER-associated protein degradation pathway. These effects ultimately reduce the overall assembly of HBV virions in the ER and their associated secretion.
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 20 (1) , 20220951
Open AccessPreliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
A growing body of evidence has shown that hepatitis B surface antigen (HBsAg) mutations can influence the occurrence of occult hepatitis B infection (OBI), particularly amino acid substitutions in small hepatitis B surface proteins (SHBs). The mechanistic basis for these results, however, remains unclear. This study was designed to explore the potential impact and mechanisms of OBI-related SHBs mutations on serum HBsAg. Huh7 and HepG2 cells were transfected with plasmids encoding wild-type (WT) or OBI-related SHB mutation-containing sequences, after which a chemiluminescence approach was used to detect HBsAg levels in cell culture supernatants. Western blotting was further used to assess HBsAg and endoplasmic reticulum stress (ERS)-related protein levels in lysates prepared from these cells, while the localization of HBsAg within cells was assessed via immunofluorescent staining. Cells transfected with OBI-related SHB mutation-encoding plasmids exhibited lower supernatant HBsAg levels than cells transfected with WT plasmids. Intracellular and extracellular HBsAg levels in these mutant plasmid-transfected cells were lower relative to those for WT plasmid-transfected cells, and HBsAg accumulation within the ER was detected via immunofluorescent staining in cells transfected with OBI-related SHB mutation-encoding plasmids, ERS-related protein content was also significantly increased in mutant plasmid-transfected cells as compared to those in the WT group. These results suggest that proteins harboring OBI-related mutations may tend to accumulate in the ER, thereby triggering an ERS response and impairing the transcription and translation of HBsAg via the activation of the unfolded protein response and ER-associated protein degradation pathway. These effects ultimately reduce the overall assembly of HBV virions in the ER and their associated secretion.
- Open Access
- 4 December 2024
- Published by Elsevier in Immunobiology
- Vol. 230 (1) , 152860
STING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization
- 4 December 2024
- Published by Elsevier in Immunobiology
- Vol. 230 (1) , 152860
Open AccessSTING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization
- Open Access
- 17 May 2024
- Published by Elsevier in Immunobiology
- Vol. 229 (3) , 152810
Activation of the cGAS-STING pathway by viral dsDNA leading to M1 polarization of macrophages mediates antiviral activity against hepatitis B virus
- 17 May 2024
- Published by Elsevier in Immunobiology
- Vol. 229 (3) , 152810
Open AccessActivation of the cGAS-STING pathway by viral dsDNA leading to M1 polarization of macrophages mediates antiviral activity against hepatitis B virus
- 1 March 2024
- Vol. 54 (2) , 217-223
Predictive Value of Serum Albumin, Iron, Ferritin, and Hepcidin for Antiviral E ffi cacy of IFNα Treatment in Patients with Chronic Hepatitis B
Objective. Interferon-alpha (IFN alpha) therapy has been an integral part of the current treatment for hepatitis B virus (HBV) infection. However, the exact effect of IFN alpha antiviral therapy on liver function and iron metabolism in patients with chronic hepatitis B (CHB) remains unclear. Here, we investigated the characteristics of changes in liver function and iron metabolism indexes in patients with chronic hepatitis B before and after IFN alpha treatment. Additionally, we determined their predictive value for the therapeutic response of IFN alpha treatment. Methods. In this study, 34 patients with CHB before and after IFN alpha treatment were enrolled. Serum levels of virological indicators, liver function, and iron metabolism markers were detected and analyzed in each patient. ROC curve analysis was performed to compare the predictive value of serum liver function and iron metabolism markers for the therapeutic response of IFN alpha treatment. Results. A significant decrease in serum HBV DNA (P<0.001) and HBsAg (P<0.001) was observed before and after IFN alpha treatment. Compared to the patients before IFN alpha treatment, patients after IFN alpha treatment showed a significant increase in serum albumin (ALB) (P<0.05) and a significant decrease in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P=0.003 and P=0.034). These findings suggested that the synthetic function of the liver was improved, and liver inflammation was alleviated. Serum HEPC and serum ferritin (SF) levels in patients after IFN alpha treatment were significantly higher (P<0.001, P<0.001); however, serum iron (SI) levels were significantly lower (P=0.005) than those in patients before IFN alpha treatment. These findings indicate that IFN alpha treatment regulated iron metabolism homeostasis in CHB patients. Combined liver function and iron metabolism markers, including ALB, SI, SF, and HEPC, had the highest predictive value for the therapeutic response of IFN alpha treatment for CHB. Conclusion. IFN alpha treatment improved liver function and iron metabolism homeostasis in patients with CHB. Regular monitoring of serum ALB, SI, SF, and HEPC can help predict the therapeutic response of IFN alpha treatment for CHB.
- 1 March 2024
- Vol. 54 (2) , 217-223
Predictive Value of Serum Albumin, Iron, Ferritin, and Hepcidin for Antiviral E ffi cacy of IFNα Treatment in Patients with Chronic Hepatitis B
Objective. Interferon-alpha (IFN alpha) therapy has been an integral part of the current treatment for hepatitis B virus (HBV) infection. However, the exact effect of IFN alpha antiviral therapy on liver function and iron metabolism in patients with chronic hepatitis B (CHB) remains unclear. Here, we investigated the characteristics of changes in liver function and iron metabolism indexes in patients with chronic hepatitis B before and after IFN alpha treatment. Additionally, we determined their predictive value for the therapeutic response of IFN alpha treatment. Methods. In this study, 34 patients with CHB before and after IFN alpha treatment were enrolled. Serum levels of virological indicators, liver function, and iron metabolism markers were detected and analyzed in each patient. ROC curve analysis was performed to compare the predictive value of serum liver function and iron metabolism markers for the therapeutic response of IFN alpha treatment. Results. A significant decrease in serum HBV DNA (P<0.001) and HBsAg (P<0.001) was observed before and after IFN alpha treatment. Compared to the patients before IFN alpha treatment, patients after IFN alpha treatment showed a significant increase in serum albumin (ALB) (P<0.05) and a significant decrease in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P=0.003 and P=0.034). These findings suggested that the synthetic function of the liver was improved, and liver inflammation was alleviated. Serum HEPC and serum ferritin (SF) levels in patients after IFN alpha treatment were significantly higher (P<0.001, P<0.001); however, serum iron (SI) levels were significantly lower (P=0.005) than those in patients before IFN alpha treatment. These findings indicate that IFN alpha treatment regulated iron metabolism homeostasis in CHB patients. Combined liver function and iron metabolism markers, including ALB, SI, SF, and HEPC, had the highest predictive value for the therapeutic response of IFN alpha treatment for CHB. Conclusion. IFN alpha treatment improved liver function and iron metabolism homeostasis in patients with CHB. Regular monitoring of serum ALB, SI, SF, and HEPC can help predict the therapeutic response of IFN alpha treatment for CHB.
- Open Access
- 1 May 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 2611-2623
Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
Purpose: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. Patients and Methods: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. Results: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (− 2.80± 0.21 vs 0.97± 0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. Conclusion: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality. Graphical Abstract:
- 1 May 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 2611-2623
Open AccessPrealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
Purpose: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. Patients and Methods: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. Results: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (− 2.80± 0.21 vs 0.97± 0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. Conclusion: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality. Graphical Abstract:
- Open Access
- 9 February 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1060053
Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis
Backgrounds & aims: Epstein-Barr virus (EBV) infection occurs commonly in children and may cause acute infectious mononucleosis (AIM) and various malignant diseases. Host immune responses are key players in the resistance to EBV infection. We here assessed the immunological events and laboratory indicators of EBV infection, as well as determined the clinical usefulness of evaluating the severity and efficacy of antiviral therapy in AIM patients.Methods: We enrolled 88 children with EBV infection. The immune environment was defined by immunological events such as frequencies of lymphocyte subsets, phenotypes of T cells, and their ability to secrete cytokines, and so on. This environment was analyzed in EBV-infected children with different viral loads and in children in different phases of infectious mononucleosis (IM) from disease onset to convalescence.Results: Children with AIM had higher frequencies of CD3+ T and CD8+ T cells, but lower frequencies of CD4+ T cells and CD19+ B cells. In these children, the expression of CD62L was lower and that of CTLA-4 and PD-1 was higher on T cells. EBV exposure induced granzyme B expression, but reduced IFN-γ secretion, by CD8+ T cells, whereas NK cells exhibited reduced granzyme B expression and increased IFN-γ secretion. The frequency of CD8+ T cells was positively correlated with the EBV DNA load, whereas the frequencies of CD4+ T cells and B cells were negatively correlated. During the convalescent phase of IM, CD8+ T cell frequency and CD62L expression on T cells were restored. Moreover, patient serum levels of IL-4, IL-6, IL-10, and IFN-γ were considerably lower throughout the convalescent phase than throughout the acute phase.Conclusion: Robust expansion of CD8+ T cells, accompanied by CD62L downregulation, PD-1 and CTLA-4 upregulation on T cells, enhanced granzyme B production, and impaired IFN-γ secretion, is a typical characteristic of immunological events in children with AIM. Noncytolytic and cytolytic effector functions of CD8+ T cells are regulated in an oscillatory manner. Furthermore, the AST level, number of CD8+ T cells, and CD62L expression on T cells may act as markers related to IM severity and the effectiveness of antiviral treatment.
- 9 February 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1060053
Open AccessCharacteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis
Backgrounds & aims: Epstein-Barr virus (EBV) infection occurs commonly in children and may cause acute infectious mononucleosis (AIM) and various malignant diseases. Host immune responses are key players in the resistance to EBV infection. We here assessed the immunological events and laboratory indicators of EBV infection, as well as determined the clinical usefulness of evaluating the severity and efficacy of antiviral therapy in AIM patients.Methods: We enrolled 88 children with EBV infection. The immune environment was defined by immunological events such as frequencies of lymphocyte subsets, phenotypes of T cells, and their ability to secrete cytokines, and so on. This environment was analyzed in EBV-infected children with different viral loads and in children in different phases of infectious mononucleosis (IM) from disease onset to convalescence.Results: Children with AIM had higher frequencies of CD3+ T and CD8+ T cells, but lower frequencies of CD4+ T cells and CD19+ B cells. In these children, the expression of CD62L was lower and that of CTLA-4 and PD-1 was higher on T cells. EBV exposure induced granzyme B expression, but reduced IFN-γ secretion, by CD8+ T cells, whereas NK cells exhibited reduced granzyme B expression and increased IFN-γ secretion. The frequency of CD8+ T cells was positively correlated with the EBV DNA load, whereas the frequencies of CD4+ T cells and B cells were negatively correlated. During the convalescent phase of IM, CD8+ T cell frequency and CD62L expression on T cells were restored. Moreover, patient serum levels of IL-4, IL-6, IL-10, and IFN-γ were considerably lower throughout the convalescent phase than throughout the acute phase.Conclusion: Robust expansion of CD8+ T cells, accompanied by CD62L downregulation, PD-1 and CTLA-4 upregulation on T cells, enhanced granzyme B production, and impaired IFN-γ secretion, is a typical characteristic of immunological events in children with AIM. Noncytolytic and cytolytic effector functions of CD8+ T cells are regulated in an oscillatory manner. Furthermore, the AST level, number of CD8+ T cells, and CD62L expression on T cells may act as markers related to IM severity and the effectiveness of antiviral treatment.
- 22 February 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 107, 108641
Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver
- 22 February 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 107, 108641
Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver